- Home
- VNRX vs DMA Comparison
VNRX vs DMA Comparison
Compare VNRX & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- DMA
- Stock Information
- Founded
- VNRX N/A
- DMA 2011
- Country
- VNRX United States
- DMA United States
- Employees
- VNRX N/A
- DMA N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- DMA Trusts Except Educational Religious and Charitable
- Sector
- VNRX Health Care
- DMA Finance
- Exchange
- VNRX Nasdaq
- DMA Nasdaq
- Market Cap
- VNRX 67.2M
- DMA 78.6M
- IPO Year
- VNRX N/A
- DMA N/A
- Fundamental
- Price
- VNRX $0.68
- DMA $8.78
- Analyst Decision
- VNRX Strong Buy
- DMA
- Analyst Count
- VNRX 4
- DMA 0
- Target Price
- VNRX $4.17
- DMA N/A
- AVG Volume (30 Days)
- VNRX 135.1K
- DMA 34.6K
- Earning Date
- VNRX 11-14-2024
- DMA 01-01-0001
- Dividend Yield
- VNRX N/A
- DMA 2.04%
- EPS Growth
- VNRX N/A
- DMA N/A
- EPS
- VNRX N/A
- DMA N/A
- Revenue
- VNRX $1,285,827.00
- DMA N/A
- Revenue This Year
- VNRX $180.66
- DMA N/A
- Revenue Next Year
- VNRX $558.69
- DMA N/A
- P/E Ratio
- VNRX N/A
- DMA N/A
- Revenue Growth
- VNRX 88.32
- DMA N/A
- 52 Week Low
- VNRX $0.43
- DMA $4.78
- 52 Week High
- VNRX $1.23
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- VNRX 50.19
- DMA 50.21
- Support Level
- VNRX $0.55
- DMA $8.84
- Resistance Level
- VNRX $0.80
- DMA $9.00
- Average True Range (ATR)
- VNRX 0.07
- DMA 0.13
- MACD
- VNRX 0.01
- DMA 0.00
- Stochastic Oscillator
- VNRX 52.00
- DMA 52.17
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.